Assessment of the Rosacea Prevalence in the General Population (RISE)

Galderma

Status: Completed

Conditions: Rosacea

Treatments: Other: Prevalence assessment

Study type: Observational

Funder types: Industry

Identifiers

NCT02292797

RD.03.SPR.29104

Details and patient eligibility

About

Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.

Full description

Primary objective:

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

Enrollment: 6,000 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Part I

Inclusion Criteria:

The following subjects will be included in the study:

• Subjects aged 18 to 65 years old from the general population
• Subjects who are willing to complete the questionnaires

Part II

Inclusion Criteria:

The following subjects will be included in Part II of the study:

• Subjects who screened positive for rosacea during the first part of the study and selected by random method
• Subjects who gave their informed consent to participate in Part II of the study